These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 10582456)

  • 1. Dealing with a special group: hypertrophic cardiomyopathy. Etiology and prevalence: what is known today.
    Komajda M
    Rev Port Cardiol; 1999 Sep; 18 Suppl 5():V41-4. PubMed ID: 10582456
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypertrophic cardiomyopathy: etiology, diagnosis, and treatment.
    Ramaraj R
    Cardiol Rev; 2008; 16(4):172-80. PubMed ID: 18562807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular etiology of idiopathic cardiomyopathy in Asian populations.
    Kimura A; Ito-Satoh M; Hayashi T; Takahashi M; Arimura T
    J Cardiol; 2001; 37 Suppl 1():139-46. PubMed ID: 11433818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypertrophic myocardiopathy: a sarcomere disease?].
    Gonçalves L; Vieira M; Faro C; Providência LA
    Rev Port Cardiol; 1997 Nov; 16(11):853-60, 847. PubMed ID: 9477718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of hypertrophic cardiomyopathy in China.
    Cheng TO
    Chin Med J (Engl); 2004 Oct; 117(10):1600. PubMed ID: 15536665
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypertrophic cardiomyopathy centers.
    Maron BJ
    Am J Cardiol; 2009 Oct; 104(8):1158-9. PubMed ID: 19801041
    [No Abstract]   [Full Text] [Related]  

  • 7. Dealing with a special group: hypertrophic cardiomyopathy. The role of electrophysiology and pacing in hypertrophic cardiomyopathy.
    de Sousa J
    Rev Port Cardiol; 1999 Sep; 18 Suppl 5():V51-3. PubMed ID: 10582459
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype.
    Kubo T; Gimeno JR; Bahl A; Steffensen U; Steffensen M; Osman E; Thaman R; Mogensen J; Elliott PM; Doi Y; McKenna WJ
    J Am Coll Cardiol; 2007 Jun; 49(25):2419-26. PubMed ID: 17599605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The epidemiologic evolution and present perception of hypertrophic cardiomyopathy.
    Olivotto I; Cecchi F
    Ital Heart J; 2003 Sep; 4(9):596-601. PubMed ID: 14635376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypertrophic cardiomyopathy and sudden death].
    Piccininno M; Spirito P
    Recenti Prog Med; 2001 Mar; 92(3):205-8. PubMed ID: 11320853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertrophic cardiomyopathy.
    Ommen SR; Nishimura RA
    Curr Probl Cardiol; 2004 May; 29(5):239-91. PubMed ID: 15123994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apical hypertrophic cardiomyopathy in association with Takayasu's arteritis.
    Satish OS; Ravikumar A; Koshy G; Patnaik AN; Rao DS
    Indian Heart J; 2002; 54(2):208-11. PubMed ID: 12086390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening.
    Basavarajaiah S; Wilson M; Whyte G; Shah A; McKenna W; Sharma S
    J Am Coll Cardiol; 2008 Mar; 51(10):1033-9. PubMed ID: 18325444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy.
    Monserrat L; Gimeno-Blanes JR; Marín F; Hermida-Prieto M; García-Honrubia A; Pérez I; Fernández X; de Nicolas R; de la Morena G; Payá E; Yagüe J; Egido J
    J Am Coll Cardiol; 2007 Dec; 50(25):2399-403. PubMed ID: 18154965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sarcomere gene mutations--a cause of hypertrophic cardiomyopathy].
    Kuusisto J; Jääskeläinen P; Laakso M
    Duodecim; 1999; 115(9):997-8. PubMed ID: 11877825
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hypertrophic cardiomyopathy].
    Scheffold T; Binner P; Erdmann J; Schunkert H;
    Herz; 2005 Sep; 30(6):550-7. PubMed ID: 16170688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertrophic cardiomyopathy in China: three decades of progress.
    Cheng TO
    Int J Cardiol; 2005 Apr; 100(3):493-4. PubMed ID: 15837095
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hypertrophic cardiomyopathy in elderly: causes, diagnostic and treatment approaches].
    Chumakova OS
    Ter Arkh; 2020 Oct; 92(9):63-69. PubMed ID: 33346433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular genetics in hypertrophic cardiomyopathy: towards individualized management of the disease.
    Charron P; Komajda M
    Expert Rev Mol Diagn; 2006 Jan; 6(1):65-78. PubMed ID: 16359268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy.
    Maron MS; Finley JJ; Bos JM; Hauser TH; Manning WJ; Haas TS; Lesser JR; Udelson JE; Ackerman MJ; Maron BJ
    Circulation; 2008 Oct; 118(15):1541-9. PubMed ID: 18809796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.